Camelia Bogaert

Mrs. Camelia Bogaert

AZ Sint-Lucas, Ghent, Belgium
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in Neurology Clinical Practice
Verified
Journal Article
Closed access
CBCamelia Bogaert
Camelia Bogaert
Alfonso FasanoAlfonso Fasano
Alfonso Fasano
The aim of this narrative review was to explore the interplay between functional movement disorders (FMDs) and deep brain stimulation (DBS). Patients with unrecognized FMD who are referred for DBS usually present with functional dystonia. By contrast, patients who present with FMD after DBS are mostly presenting with functional tremor, in keeping with non-DBS FMD cohorts. Comorbid presentation of FMD in established DBS indications makes the decision to opt for surgery challenging. Many contributing factors can play a role in the development of FMD, including the trauma caused by awake neurosurgery and/or extensive DBS programming. FMDs in the context of DBS are often overlooked and should be diagnosed promptly because they determine surgical outcome. The approach to DBS candidates with comorbid FMD and the risk factors of FMD after DBS should be further explored.

8 May 2023 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
CBCamelia Bogaert
Camelia Bogaert
JPJana Peeters
Jana Peeters
TBTine Van Bogaert
Tine Van Bogaert
JRJan Rusz
Jan Rusz
CBCamelia Bogaert-Miclaus
Camelia Bogaert-Miclaus
MLMyles Mc Laughlin
Myles Mc Laughlin

30 April 2025 in Movement Disorders Clinical Practice
Verified
Journal Article
Open access
TATarig Abkur
Tarig Abkur
CBCamelia Bogaert
Camelia Bogaert
TGTalyta Grippe
Talyta Grippe
DIDavid Isaacs
David Isaacs
IMIrene A Malaty
Irene A Malaty
CGChristos Ganos
Christos Ganos
Background: The coexistence of tics with Parkinson's disease (PD) is rare, as they often emerge at different ages, follow different trajectories and involve contrasting pathophysiological mechanisms related to dopamine availability and function in the brain.Cases: We present 10 individuals with primary tic disorders who later developed PD. Tic severity remained unchanged with the onset of parkinsonism or dopaminergic treatment. Peak‐dose dyskinesias in two cases did not affect tics, and deep brain stimulation of the subthalamic nucleus transiently induced tics in one individual with PD.Conclusions: The evidence drawn from this case series does not support a linear relation between nigrostriatal dopaminergic availability and tics. It suggests that tics may instead arise from a more complex interplay between multiple neurotransmitter systems acting on several networks within the cortico‐striatal‐thalamic circuits.

28 July 2025 in Tremor and Other Hyperkinetic Movements
Verified
Journal Article
Open access
PDF file
MJMaria Belen Justich
Maria Belen Justich
CBCamelia Bogaert
Camelia Bogaert
ALAndres M Lozano
Andres M Lozano
Alfonso FasanoAlfonso Fasano
Alfonso Fasano
Deep brain stimulation (DBS) is an increasingly utilized therapy for treating refractory tremor in Parkinson’s disease (PD). Remote care can improve patient access to specialized DBS clinics. Here, we present a novel strategy to assess tremor remotely during DBS programming. We report the case of a 65-year-old female diagnosed with PD who showed only partial responsiveness to levodopa. She underwent bilateral subthalamic nucleus DBS surgery and was implanted with an Infinity™ implantable pulse generator with directional leads (Abbott, Chicago, IL, USA). Given that she resided 1,500 km from our center, device programming was performed remotely using the Neurosphere™ Virtual Clinic platform. The patient was instructed to hold her controller in a fixed position until her resting tremor re-emerged, which was visibly evident through a shaking video frame. Stimulation parameters were then optimized until the video frame became still. She reported sustained benefit during follow-up. We propose that this alternative method for remotely assessing upper limb tremor may offer advantages for healthcare providers, allowing them to base stimulation adjustments on visually observable tremor severity.


14 January 2026 in Movement Disorders
Verified
Journal Article
Open access
ABArjun Balachandar
Arjun Balachandar
CBCamelia Bogaert
Camelia Bogaert
SNSara Naghdlou
Sara Naghdlou
ALAndres M. Lozano
Andres M. Lozano
SKSuneil K. Kalia
Suneil K. Kalia
Alfonso FasanoAlfonso Fasano
Alfonso Fasano
Background: Neurophysiological biomarkers in Parkinson's disease (PD) are increasingly used for deep brain stimulation (DBS). Their long‐term utility is not clear, especially when transitioning to sensing‐guided DBS years post‐surgery. Objectives: Beta‐band power, bursting activity, and periodic and aperiodic components of local field potentials recorded from DBS electrodes in the subthalamic nucleus (STN) were compared between a group of newly and chronically (6.7 ± 4.0 years) implanted PD patients. Clinical severity was rated using the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III (MDS‐UPDRS‐III). Results: Beta‐band power and burst amplitude were significantly higher and aperiodic offset and exponent were significantly lower in the chronically implanted cohort. Periodic peak frequency and power were not significantly different. Clinical severity correlated with cumulative burst time and burst rate. A longitudinal subset showed no change in peak frequency or power. Conclusions: STN beta‐band‐related biomarkers inform disease state of de novo and chronic PD‐DBS cohorts, with signal properties relevant for sensing‐guided DBS preserved over time. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.